Research Update: Eksportfinans ASA Outlook To Negative On Weakened Business Model And Concerns Over Adequacy Of ERM; Ratings Affirmed Jun 11

  • ID: 1815144
  • June 2011
  • Standard & Poors
1 of 3

Eksportfinans ASA's business model has been placed under severe pressure by regulatory changes. Eksportfinans' enterprise risk management is, in our opinion, inadequate given the complexity of its business operations, which include the active management of a sizable portfolio of structured funding transactions. We are affirming our long-term issuer credit rating based on our continued belief in the "very high likelihood" of the Norwegian government's willingness to support Eksportfinans. We are changing our outlook on Eksportfinans to negative from stable to reflect our view of the ongoing pressure on Eksportfinans' stand-alone credit profile stemming from the viability of its current business model and the adequacy of its enterprise risk management. On June 7, 2011, Standard & Poor's Ratings Services affirmed its...

Companies mentioned in this report are:
- Eksportfinans ASA

Action: Affirmed
Action: Outlook: Negative

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit READ MORE >

Note: Product cover images may vary from those shown
2 of 3

- Eksportfinans ASA

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.